Skip to Main Content

RenovoRx, Inc. Common Stock

RNXT Real Time Price USD
N/A
N/A
N/A
...
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of RNXT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
RNXT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
RNXT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
RNXT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by RNXT's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

RNXT Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
RNXT Income Statement
RNXT Balance Sheet
RNXT Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Methods for delivery of therapeutic materials to treat cancer Jan. 03, 2023
  • Patent Title: Methods for treating cancerous tumors Jul. 06, 2021
  • Patent Title: Methods for treating cancerous tumors Jun. 30, 2020
  • Patent Title: Methods for delivery of therapeutic materials to treat pancreatic cancer Dec. 24, 2019
  • Patent Title: Occlusion catheter system and methods of use Oct. 16, 2018
  • Patent Title: Devices, methods and kits for delivery of therapeutic materials to a pancreas Oct. 11, 2016
  • Patent Title: Devices, methods and kits for delivery of therapeutic materials to a target artery Oct. 04, 2016
  • Patent Title: Devices, methods and kits for delivery of therapeutic materials to a pancreas Sep. 02, 2014
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
RNXT News

Recent insights relating to RNXT

WallStreetBets

Number of mentions of RNXT in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for RNXT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in RNXT

RNXT Analyst Ratings

RNXT Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
RNXT Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $RNXT stock a Buy, Sell, or Hold?

  • What is the price target for $RNXT stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

RNXT Top Shareholders
Shareholder
Shares Held
RNXT Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $RNXT stock?

  • Who owns the most shares of $RNXT stock?

  • What funds own $RNXT stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

RNXT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view RNXT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top